The company having truncated its last project in Croatia is continuing to seek and review advanced Pharmaceutical & Medical projects. I believe that the Pharmaceutical & Medical sector is not only going to remain strong but expand with the world population becoming larger and more specifically the elderly population.
The foregoing opinion & statement certainly is a forward-looking statement, and since I'm about to make more of the same, I urge you to read the "Cautionary Disclaimer" available on the Company's website, and as referred to again later in this presentation.
The Company, having faced the past economic difficult times caused due to the Covid epidemic and subsequent high interest rates to fight inflation, and due to Croatia not legislating the necessary laws on medical marijuana use on a timely basis terminated its initial project in Croatia, part of the European Union ("EU"), Additionally, the Company controlled it costs to a minimal level to restrict shareholder dilution. With the interest rates finally starting to recede, the Company once again has commenced its pursuit to acquire advanced pharmaceutical and medical assets, especially with emphasis on artificial intelligence ("AI").
Based on current global economic, social, political, environmental & ecological dynamics & the transforming trends emerging at a time when the world population growth, especially of the elderly reaches new highs, the demand for pharmaceutical and medical assets, especially catering to the elderly, will reach highest levels both in the established westernized economies and the emerging economies. And, this is all happening when the pharmaceutical sector needs to regroup after the Covid issues; somewhat of a disarray. Read CEO & Chairman's full Message ...
